Shareholders Equity (Quarterly) Chart

View Shareholders Equity (Quarterly) for ADTX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shareholders Equity (Quarterly) Chart
Start Trial

Historical Shareholders Equity (Quarterly) Data

View and export this data back to 2017. Start Trial.
Date Value
March 31, 2026 -33.28M
December 31, 2025 5.610M
September 30, 2025 -7.733M
June 30, 2025 12.96M
March 31, 2025 16.59M
December 31, 2024 8.870M
September 30, 2024 4.712M
June 30, 2024 6.566M
March 31, 2024 9.930M
December 31, 2023 16.06M
September 30, 2023 -4.222M
June 30, 2023 -3.869M
March 31, 2023 0.0681M
December 31, 2022 5.206M
September 30, 2022 12.69M
June 30, 2022 1.361M
March 31, 2022 4.723M
Date Value
December 31, 2021 10.18M
September 30, 2021 12.97M
June 30, 2021 5.964M
March 31, 2021 11.37M
December 31, 2020 11.01M
September 30, 2020 13.75M
June 30, 2020 -3.712M
March 31, 2020 -3.524M
December 31, 2019 -2.852M
September 30, 2019
June 30, 2019
March 31, 2019
December 31, 2018 -1.537M
September 30, 2018
June 30, 2018
March 31, 2018
December 31, 2017 -0.0599M

Shareholders' Equity Definition

Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.

Read full definition.

Shareholders Equity (Quarterly) Range, Past 5 Years

View Shareholders Equity (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shareholders Equity (Quarterly) Benchmarks

View Shareholders Equity (Quarterly) Benchmarks
Start Trial
Athersys, Inc. --
Marizyme, Inc. --
RenovaCare, Inc. --
Mera Pharmaceuticals, Inc. --
PhaseRx, Inc. --

Shareholders Equity (Quarterly) Related Metrics